Hmb Muscle Mass Randomized Trial: What the Evidence Says

Quick Answer

Hmb Muscle Mass Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Early work demonstrated that HMB can attenuate exercise-induced muscle proteolysis and damage, leading to improved training outcomes. [Tayebi Seyed Morteza (2026); evidence level 2]
• The protocol consisted of four consecutive bouts of judo-specific activity, each separated by rest intervals similar to those found in tournament progression (30 min between Bout 1 and 2, 30 min between Bout 2 and 3, and 60 min between Bout 3 and 4). [Tayebi Seyed Morteza (2026); evidence level 2]
• Older age is associated with declines in skeletal muscle mass, strength and function, termed sarcopenia. [Smith Kenneth (2026); evidence level 2]
• Involving motor unit remodelling and muscle fibre atrophy as a result of lifestyle, genetic and disease interactions, sarcopenia is a major hurdle to improving health-span against the backdrop of increasing lifespan. [Smith Kenneth (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For hmb muscle mass randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Tayebi Seyed Morteza (2026). Effects of acute HMB-FA supplementation on antioxidant status and muscle damage in Elite Judoka: a randomized pilot trial. DOI: 10.1080/15502783.2026.2665962. PMCID: PMC13148084. PMID: 42084797. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13148084/
• Smith Kenneth (2026). The Effect of β-Hydroxy-β-Methyl Butyrate (HMB) upon Acute Fed-State Muscle Protein Turnover in Older Men and Women: A Randomized Double-Blind Controlled Crossover Clinical Trial. DOI: 10.3390/nu18091449. PMCID: PMC13165317. PMID: 42124050. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165317/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.